3rd ACHA-presentations

What should we do to cure HBV
Dr. Stephen Locarnini
English version // Chinese version
Hepatitis B virus genotypes: clinical significance and biological characterization
Dr. Shuping Tong
English version // Chinese version
Antiviral therapy of HBV/HCV in China from clinical perspective
Dr. Jidong Jia
English version // Chinese version
Prevalence of Hepatitis B Infection and Factors Associated with Hepatitis B Immunization among Men Who Have Sex with Men in Beijing, China
Dr. Chao Wang
English version
HIV Cure
Dr. Sharon Lewin
English version // Chinese version
HIV co-infections from a European perspective
Dr. Jürgen Rockstroh
English version // Chinese version
HIV clinical implications
Dr. Taisheng Li
English version // Chinese version
Rationale for starting therapy early
Dr. Charles Boucher
English version // Chinese version
Update on HIV Drug Resistance
Dr. Bonaventura Clotet
English version
 Treatment strategies in special populations (women, aging patients, late presenters)
Dr. Jürgen Rockstroh
English version // Chinese version
Can antiviral treatment reduce HCC in CHB patients?
Dr. Hou (presentation not available)
Changes from quantity to quality : the true story of HBeAg
Dr. Yongwe 
Chinese version
Danoprevir, an HCV PI Tailored for Chinese Patients
Dr. Jinzi Wu (presentation not available)
Has treating HBV reduced liver cancer incidence?
Dr. Jinlin Hou
English version // Chinese version
How does HBV cause cancer?
Dr. Fengmin Lu  (presentation not available)
HBV Entry and Receptor
Dr. Wenhui Li  (presentation not available)
Can chronic hepatitis B be cured? Evidence from clinical and basic studies
Dr. Fusheng Wang  (presentation not available)
Innate immune responses to HCV infection
Dr. Kui Li  (presentation not available)
Hepatitis C disease burden from Asian perspective
Dr. Hui Zhuang
English version // Chinese version
Current Therapeutic options in HCV - AbbVie Satellite
Dr. Hui Zhang ---- Dr. Lai Wei ---- Dr. Ashley Brown
English version // Chinese version
DAA in chronic hepatitis C: what is difference between west and east
Dr. Lai Wei  (presentation not available)
IL-28B genotype, to detect or not to detect
Dr. Huiying Rao
English version // Chinese version
Clinical management of Hepatitis C patients: to treat or to wait
Dr. Ed Gane
English version // Chinese version
Managing HCV in HIV infected patients
Dr. Weiping Cai  (presentation not available)
Managing HCV in cirrhotic patients
Dr. Qing Xie
English version // Chinese version
Alisporivir (ALV) –containing treatment achieves high response rates in difficult-to-treat Asian chronic hepatitis C (CHC) patients
Dr. Huiying Rao  (presentation not available)